Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

NCT00335712 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ONO-5129

Sponsor

Ono Pharma USA Inc